These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1690870)

  • 1. Analysis of mutant forms of the c-src gene product containing a phenylalanine substitution for tyrosine 416.
    Ferracini R; Brugge J
    Oncogene Res; 1990; 5(3):205-19. PubMed ID: 1690870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.
    Espino PC; Harvey R; Schweickhardt RL; White GA; Smith AE; Cheng SH
    Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
    Potts WM; Reynolds AB; Lansing TJ; Parsons JT
    Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS; Parsons JT
    Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells.
    Kanner SB; Parsons SJ; Parsons JT; Gilmer TM
    Oncogene; 1988 Apr; 2(4):327-35. PubMed ID: 2452399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of Src mutants at Tyr 527 in fibroblasts does not correlate with in vitro phosphorylation by CSK.
    MacAuley A; Okada M; Nada S; Nakagawa H; Cooper JA
    Oncogene; 1993 Jan; 8(1):117-24. PubMed ID: 7678701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
    Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
    Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of carboxyl terminal truncation and point mutations on pp60c-src activities.
    Yaciuk P; Cannella MT; Shalloway D
    Oncogene Res; 1988 Sep; 3(2):207-12. PubMed ID: 2465526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific kinase activity and phosphorylation state of pp60c-src from neuroblastomas and fibroblasts.
    Yang XM; Walter G
    Oncogene; 1988 Sep; 3(3):237-44. PubMed ID: 2462704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avian pp60c-src is more active when expressed in yeast than in vertebrate fibroblasts.
    Cooper JA; Runge K
    Oncogene Res; 1987; 1(4):297-310. PubMed ID: 2453017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From c-src to v-src, or the case of the missing C terminus.
    Sefton BM; Hunter T
    Cancer Surv; 1986; 5(2):159-72. PubMed ID: 2430701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo phosphorylation states and kinase activities of transforming p60c-src mutants.
    Jove R; Hanafusa T; Hamaguchi M; Hanafusa H
    Oncogene Res; 1989; 5(1):49-60. PubMed ID: 2476707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
    Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
    J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
    Lansing TJ; Turk BF; Kanner SB; Gilmer TM
    Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.
    Jackson PK; Paskind M; Baltimore D
    Oncogene; 1993 Jul; 8(7):1943-56. PubMed ID: 8510937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation by polyoma virus middle T antigen.
    Courtneidge SA
    Cancer Surv; 1986; 5(2):173-82. PubMed ID: 2430702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution of Ser-17 of pp60c-src: biological and biochemical characterization in chicken embryo fibroblasts.
    Hirota Y; Kato J; Takeya T
    Mol Cell Biol; 1988 Apr; 8(4):1826-30. PubMed ID: 2454397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between c-src tyrosine kinase activity and the control of glucose transporter gene expression.
    Matsouka PT; Flier JS
    Mol Endocrinol; 1989 Nov; 3(11):1845-51. PubMed ID: 2481817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular src gene product regulates junctional cell-to-cell communication.
    Azarnia R; Reddy S; Kmiecik TE; Shalloway D; Loewenstein WR
    Science; 1988 Jan; 239(4838):398-401. PubMed ID: 2447651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.